Recombinant Human PHGDH His-tag, CF

R&D Systems | Catalog # 10131-DH

R&D Systems
100% Guarantee

Key Product Details

  • R&D Systems E. coli-derived Recombinant Human PHGDH His-tag (10131-DH)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

E. coli

Accession Number

O43175-1

Applications

Enzyme Activity
View all PHGDH Proteins and Enzymes »

Product Specifications

Source

E. coli-derived human PHGDH protein
Ala2-Phe533
with a C-terminal 6-His tag

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Ala2

Predicted Molecular Mass

57 kDa

SDS-PAGE

57 kDa, under reducing conditions

Activity

Measured by the ability to catalyze the oxidation of 3-phospho-D-glycerate.
The specific activity is >350 pmol/min/μg, as measured under the described conditions.

Scientific Data Images for Recombinant Human PHGDH His-tag, CF

Recombinant Human PHGDH His-tag Enzyme Activity

Recombinant Human PHGDH His-tag Enzyme Activity

Recombinant Human PHGDH His-tag (Catalog # 10131-DH) is measured by its ability to catalyze the oxidation of 3-phospho-D-glycerate. The activity (orange) is over 2-fold than the competitor's PHGDH (green).
Recombinant Human PHGDH His-tag SDS-PAGE

Recombinant Human PHGDH His-tag SDS-PAGE

2 μg/lane of Recombinant Human PHGDH His-tag (Catalog # 10131-DH) and 2 μg/lane of competitor Human PHGDH was resolved with 4-20 % SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie.

Formulation, Preparation, and Storage

10131-DH
Formulation Supplied as a 0.2 μm filtered solution in Tris, NaCl, Glycerol and TCEP.
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -70 °C as supplied.
  • 3 months, -70 °C under sterile conditions after opening.

Background: PHGDH

Phosphoglycerate dehydrogenase (PHGDH) catalyzes the oxidation of 3-phospho-D-glycerate to 3-phosphooxypyruvate, which is the first step of the L-serine biosynthesis pathway. Human PHGDH is a Type I NADH-dependent enzyme that forms an active oligomer where each monomer is composed of 4 domains: a substrate-binding domain, a nucleotide-binding domain, and two regulatory domains: ASB (allosteric substrate binding) and ACT (Aspartate kinase, Chorismate mutase, and Tyr A)(1). Serine biosynthesis by PHGDH is the sole source of serine biosynthesis in mammals (2) and conditional knockout confirmed L-serine synthesis by PHGDH is the source of D-serine in the brain (3). PHGDH null mice are embryonic lethal (4) and mutations that lead to PHGDH deficiency have been reported in infantile, juvenile and adult onset phenotypes (5, 6). PHGDH is also suggested to play a role in several cancers including breast (7), cervical (8), melanoma (9), colon (10), pancreatic (11), liver (12), and kidney (13) through increased PHGDH expression and enhanced tumor cell proliferation. Levels of PHGDH correlate with patient survival and may be used as a prognostic factor (14). A mutation resulting in inactive PHGDH (15), cell line knockdown (8, 11), and treatment with enzymatic inhibitors in cancer cells (13) result in decreased proliferation. Given the correlation between high PHGDH and cancer and the results from indirect inhibition of PHGDH activity, PHGDH is a pharmaceutical target for cancer therapy (16-18).

References

  1. Unterlass, J. E. et al. (2017) Oncotarget 8:104478.
  2. Mattaini, K. R. et al. (2016) J. Cell Biol. 214:249.
  3. Yang, J.H. et al. (2010) J. Biol. Chem. 285:41380.
  4. Yoshida, K. et al. (2004) J. Biol. Chem. 279:3573.
  5. Tabatabaie, L. et al. (2010) Mol. Gen. Metab. 99:256.
  6. van der Crabben, S. N. (2013) J. Inherit. Metab. 36:613.
  7. Possemato, R. et al. (2011) Nature 476:346.
  8. Jing, Z. et al. (2015) Cancer Biol. Ther. 16:541.
  9. Ou, Y. et al. (2015) J. Biol. Chem 290:457.
  10. Yoon, S. et al. (2015) Oncology 89:351.
  11. Song, Z. et al. (2018) Gene 642:43.
  12. Liu, S. et al. (2017) Hepatology 66:631.
  13. Yoshino, H. et al. (2017) Cancer Res. 77:6321.
  14. Antonov, A. et al. (2014) Oncotarget 5:11004.
  15. Mattaini, K. R. et al. (2015) Cancer Metab. 3:5.
  16. Wang, Q. et al. (2016) Cell Chem. Biol. 24:1.
  17. Ravez, S. et al. (2017) J. Med. Chem. 60:1591.
  18. Unterlass, J. E. et al. (2018) Oncotarget 9:13139.

Long Name

3-Phosphoglycerate Dehydrogenase

Alternate Names

3PGDH, PDGH3

Entrez Gene IDs

26227 (Human); 236539 (Mouse); 58835 (Rat)

Gene Symbol

PHGDH

UniProt

O43175-1

Additional PHGDH Products

Product Documents for Recombinant Human PHGDH His-tag, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Recombinant Human PHGDH His-tag, CF

For research use only

Related Research Areas

Redox Enzymes

Customer Reviews for Recombinant Human PHGDH His-tag, CF

There are currently no reviews for this product. Be the first to review Recombinant Human PHGDH His-tag, CF and earn rewards!

Have you used Recombinant Human PHGDH His-tag, CF?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

View specific protocols for Recombinant Human PHGDH His-tag, CF (10131-DH):

Materials
  • Assay Buffer:  50 mM Tris, 800 mM NaCl, 0.2 mM DTT, pH 9.0
  • Recombinant Human Phosphoglycerate Dehydrogenase (rhPHGDH) (Catalog # 10131-DH)
  • 3-Phospho-D-Glyceric Acid (PGA) (Sigma, Catalog # P8877), 200 mM stock in deionized water
  • beta -Nicotinamide Adenine Dinucleotide ( beta -NAD) (Sigma, Catalog # N6522), 100 mM stock in deionized water
  • UV Plate (Costar, Catalog # 3635)
  • Plate Reader (Model: SpectraMax Plus by Molecular Devices) or equivalent
  1. Dilute rhPHGDH to 5 µg/mL in Assay Buffer.
  2. Prepare Substrate Mixture containing 20 mM PGA and 4 mM beta -NAD in Assay Buffer.
  3. Load into a plate 50 μL of 5 μg/mL rhPHGDH, and start the reaction by adding 50 μL of Substrate Mixture. Include a Substrate Blank containing 50 μL of Assay Buffer and 50 μL of Substrate Mixture.
  4. Read plate at 340 nm (absorbance) in kinetic mode for 5 minutes.
  5. Calculate specific activity:

     Specific Activity (pmol/min/µg) =

Adjusted Vmax* (OD/min) x well volume (L) x 1012 pmol/mol
ext. coeff** (M-1cm-1) x path corr.*** (cm) x amount of enzyme (µg)

 

*Adjusted for Substrate Blank.
**Using extinction coefficient 6220 M-1cm-1.
***Using the path correction 0.32 cm.

Per Well:
  • rhPHGDH: 0.25 μg
  • PGA: 10 mM
  • beta -NAD: 2 mM

FAQs

No product specific FAQs exist for this product.

View all FAQs for Proteins and Enzymes